美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Telix Pharmaceuticals Ltd. (Uplisting)

11.97

-0.2900-2.37%

盘后：12.130.1600+1.34%18:08 EDT

成交量：13.49万

成交额：161.43万

市值：40.50亿

市盈率：133.76

高：12.25

开：12.18

低：11.83

收：12.26

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

本田旗下高端品牌讴歌停产TLX运动型轿车

刚刚！远大医药放射性核素偶联药物1类新药在中国获批临床 →

中金三连调该医药股目标价背后：多管线进入临床关键阶段

中金：维持远大医药“跑赢行业”评级升目标价至9.6港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TLX"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":11.97,"timestamp":1754510400000,"preClose":12.26,"halted":0,"volume":134930,"hourTrading":{"tag":"盘后","latestPrice":12.13,"preClose":11.97,"latestTime":"18:08 EDT","volume":125,"amount":1492.77,"timestamp":1754518089310},"delay":0,"floatShares":275410996,"shares":338382614,"eps":0.089486,"marketStatus":"盘后交易","change":-0.29,"latestTime":"08-06 18:32:12 EDT","open":12.18,"high":12.245,"low":11.83,"amount":1614273.77991,"amplitude":0.03385,"askPrice":13.9,"askSize":100,"bidPrice":11.66,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.089486,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1754524800000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":12.26,"preHourTrading":{"tag":"盘前","latestPrice":12.34,"preClose":12.26,"latestTime":"09:10 EDT","volume":4249,"amount":52483.269839,"timestamp":1754485844361},"postHourTrading":{"tag":"盘后","latestPrice":12.13,"preClose":11.97,"latestTime":"18:08 EDT","volume":125,"amount":1492.77,"timestamp":1754518089310},"volumeRatio":2.239443},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":275410996,"roa":"5.33%","roe":"13.92%","lyrEps":0.093266,"volumeRatio":2.239443,"shares":338382614,"dividePrice":0,"high":12.245,"amplitude":0.03385,"preClose":12.26,"low":11.83,"week52Low":11.83,"pbRate":"10.96","psRate":"7.95","week52High":30.36,"institutionHeld":0,"latestPrice":11.97,"eps":0.089486,"divideRate":0,"volume":134930,"delay":0,"ttmEps":0.089486,"open":12.18,"prevYearClose":15.4,"prevWeekClose":13.05,"prevMonthClose":13.59,"prevQuarterClose":16.07,"fiveDayClose":13.5,"twentyDayClose":16.92,"sixtyDayClose":17.18,"earningDate":1755705600000},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556955876","title":"本田旗下高端品牌讴歌停产TLX运动型轿车","url":"https://stock-news.laohu8.com/highlight/detail?id=2556955876","media":"车质网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556955876?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 08:53","pubTimestamp":1754268780,"startTime":"0","endTime":"0","summary":"据外媒报道，本田旗下高端品牌讴歌将于本月停止其中型运动轿车TLX的生产，以顺应消费者不断变化的需求以及汽车行业的发展趋势。第二代TLX是讴歌品牌产品线中仅存的两款轿车之一。在TLX停产后，入门级车型Integra将成为讴歌旗下唯一的轿车产品，该款车将于2026年进行改款。2024年，TLX销量为7,478辆，同比下跌55%。2025年上半年，TLX销量为3,634辆，同比下滑14%。讴歌还在专注于电动汽车领域。Brinley表示，随着RSX车型产量的提升，停产TLX将降低工厂的生产复杂度。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080408560597317b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080408560597317b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4555","TLX","BK4588","HMC","BK4099","BK4585"],"gpt_icon":0},{"id":"2553292297","title":"刚刚！远大医药放射性核素偶联药物1类新药在中国获批临床 →","url":"https://stock-news.laohu8.com/highlight/detail?id=2553292297","media":"谈思生物","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553292297?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 15:30","pubTimestamp":1753255817,"startTime":"0","endTime":"0","summary":"公开资料显示，这是远大医药和Telix公司正在研发的一款放射性核素偶联药物 。据远大医药公开资料介绍，TLX591是一款携带治疗性放射性核素的单克隆抗体产品。此前，远大医药用于诊断前列腺癌的创新RDC产品TLX591-CDx已于2023年8月在中国完成3期临床试验首例患者给药，并计划于今年二季度完成全部患者入组。TLX591和TLX591-CDx这两项创新产品在中国的3期临床试验，对于实现前列腺癌“诊疗一体化”的全面覆盖具有关键意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723160347a6bcc47a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723160347a6bcc47a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLX","LU1223082519.USD","LU1223083913.SGD","RDC","CDE","BK4017","LU1223082196.USD"],"gpt_icon":0},{"id":"2535831468","title":"中金三连调该医药股目标价背后：多管线进入临床关键阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2535831468","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535831468?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 09:24","pubTimestamp":1747272240,"startTime":"0","endTime":"0","summary":"远大医药多管线进入临床关键阶段，中金三次上调其目标价。其自研药物STC3141脓毒症II期临床成功，TLX591前列腺癌药国际III期临床获受理，并计划今年递交上市申请。同时，公司另一核药GPN02006也将在国际会议上公布研究成果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515094230975a1599&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515094230975a1599&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLX","00512"],"gpt_icon":0},{"id":"2535057709","title":"中金：维持远大医药“跑赢行业”评级 升目标价至9.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535057709","media":"新浪网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535057709?lang=zh_cn&edition=fundamental","pubTime":"2025-05-14 10:10","pubTimestamp":1747188629,"startTime":"0","endTime":"0","summary":"中金发布研报称，维持远大医药2025年/2026年EPS预测0.6/0.63港币不变。该行维持“跑赢行业”评级，考虑到公司RDC管线接近收获，上调目标价20.0%至9.6港币，对应2025年/2026年16.0倍/15.2倍市盈率，较当前股价有15.4%的上行空间。5月7日，公司公告创新RDC产品TLX591加入国际多中心III期临床试验的申请已经获得国家药监局受理。在本III期临床研究里，公司拟在超过100例前列腺癌患者中评估TLX591-CDx的有效性和安全性，现已完成全部患者入组给药，公司计划今年内提交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051410390294f63205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051410390294f63205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLX"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"date":"2025-08-21","symbol":"TLX","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755763200000,"name":null,"time":"","dateTimestamp":1755748800000,"actualEps":null},{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1751601600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2025-08-05","current":125.608082,"percent":0,"low":125.608082,"twenty":164.276214,"median":173.155042,"eighty":185.289127,"high":205.576265,"avg":173.996441,"sd":14.501891,"marketCap":4054989223.95},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1},{"date":"2025-06-13","current":167.838743,"twenty":167.88049,"median":176.508379,"eighty":187.45928,"marketCap":5463186103.94},{"date":"2025-06-20","current":168.923551,"twenty":167.889662,"median":176.029393,"eighty":187.353158,"marketCap":5442074695.06},{"date":"2025-06-27","current":165.669807,"twenty":167.592888,"median":175.625224,"eighty":187.337752,"marketCap":5412704421.76},{"date":"2025-07-03","current":162.348276,"twenty":167.428163,"median":175.082406,"eighty":187.024133,"marketCap":5325445922.59},{"date":"2025-07-11","current":163.297285,"twenty":166.671427,"median":174.480785,"eighty":186.439488,"marketCap":5350247552.51},{"date":"2025-07-18","current":171.228286,"twenty":165.90028,"median":173.909122,"eighty":186.045921,"marketCap":5541358073.91},{"date":"2025-07-25","current":144.045965,"twenty":165.670181,"median":173.731386,"eighty":185.637634,"marketCap":4750367012.62},{"date":"2025-08-01","current":136.589468,"twenty":164.955304,"median":173.25664,"eighty":185.381192,"marketCap":4384547406.6},{"date":"2025-08-05","current":125.608082,"twenty":164.276214,"median":173.155042,"eighty":185.289127,"marketCap":4054989223.95}],"updateTime":1754510134859}}}